T– and B–Cell Responses to Different Hepatitis C Virus Antigens in Patients With Chronic Hepatitis C Infection and in Healthy Anti– Hepatitis C Virus—Positive Blood Donors Without Viremi
Martin Lechmann(Roche (Switzerland)), Ulrich Spengler(University of Bonn), I Braunschweiger(University of Bonn), B. Matz(University of Bonn), Tilman Sauerbruch(University Hospital Bonn), Rolf Kaiser, G. Jung(University of Bonn), Hans Georg Ihlenfeldt(University of Bonn), G. Giers(University of Bonn)
Cited by 149
Related Papers
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
|Hepatology|2008|345
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
|American Journal Of Pathology|2005|171
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
|Proceedings of the National Academy of Sciences|2003|170